<><><>
[HTML] Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis
PR Gajjala, P Singh, V Odayar, HH Ediga… - International Journal of …, 2023
… Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that is
often fatal due to the formation of irreversible scar tissue in the distal areas of the
lung. Although the pathological and radiological features of IPF … the survival of …
- -特発性肺線維症におけるウィルムス腫瘍1駆動の線維芽細胞活性化と胸膜下肥厚
Now we know: chronic exposure to air pollutants is a risk factor for the development of idiopathic pulmonary fibrosis
L Sesé, S Harari - European Respiratory Journal, 2023
… Idiopathic pulmonary fibrosis (IPF) is the most common and most severe form of
idiopathic interstitial pneumonia, characterised by progressive deterioration of
respiratory function, few treatment options and poor outcomes [1]. Its natural history …
- 現在、大気汚染物質への慢性的な曝露は、特発性肺線維症の発症の危険因子
[HTML] Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
JH Lee, HJ Park, S Kim, YJ Kim, HC Kim - BMC Pulmonary Medicine, 2023
Idiopathic pulmonary fibrosis (IPF) is frequently accompanied by comorbidities, with
the management of these comorbidities crucial for clinical outcomes. This study
investigated the prevalence, incidence, changes over time, and clinical impact of …
- 特発性肺線維症の疫学と合併症：全国コホート研究
[HTML] Russian Registry of Idiopathic Pulmonary Fibrosis: Clinical Features, Treatment Management, and Outcomes
S Chikina, A Cherniak, Z Merzhoeva, I Tyurin… - Life, 2023
… Idiopathic pulmonary fibrosis (IPF) is a specific variant of chronic progressive
interstitial pneumonia of unknown etiology. IPF occurs prevalently in elderly patients
and is characterized by the rapid development of progressive respiratory failure and …
- 特発性肺線維症のロシアのレジストリ: 臨床的特徴、治療管理、および結果
[HTML] Factors associated with dose reduction of pirfenidone in patients with idiopathic pulmonary fibrosis: A study based on real-world clinical data
J Kim, C Chung, HS Cho, HC Kim - Plos one, 2023
Introduction Although pirfenidone slows disease progression in patients with
idiopathic pulmonary fibrosis (IPF), in clinical practice, patients often cannot tolerate
the recommended dose because of several adverse events. This study aimed to …
- 特発性肺線維症患者におけるピルフェニドンの減量に関連する要因：実際の臨床データに基づく研究
Idiopathic Pulmonary Fibrosis Presenting with Concurrent Hypereosinophilic Syndrome: A Case Report
A Ashraf, W Lam - Journal of Allergy and Clinical Immunology, 2023
… Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by
worsening dyspnea, decline in forced vital capacity, and … of concurrent IHES with
IPF. There is a need for research to evaluate the role of eosinophilia in the …
- 同時性好酸球増多症候群を呈する特発性肺線維症：症例報告
Idiopathic pleuroparenchymal fibroelastosis
T Franquet, AG Palleiro - Radiología (English Edition), 2022
… pleural “cap”, a term applied to a pattern of focal pulmonary fibrosis characterised
by irregular pleural thickening of less than 5 mm located at … Compared with
idiopathic pulmonary fibrosis (IPF), the frequency of spontaneous pneumothorax is …
- 特発性胸膜実質線維弾性症
[PDF] Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
LB Jehn, U Costabel, E Boerner, J Wälscher… - Journal of Clinical Medicine, 2023
… develops over time in patients with idiopathic pulmonary fibrosis (IPF) and in 18–32%
of … a validated prediction tool for mortality risk in idiopathic pulmonary fibrosis (IPF)
[6] and other … slightly better prediction of mortality, especially in IPF and …
- 線維性間質性肺疾患における任意の時点での進行のバイオマーカーとしての血清 KL-6
New Frontiers in Therapeutics for Interstitial Lung Diseases
N Mesfin, R Sangani, DA Shankar, C Reardon - American Journal of Respiratory and …, 2023
… However, extrapolating these benefits to other lung diseases such as idiopathic
pulmonary fibrosis (IPF) remains an open question. This question becomes more
salient in light of the fact that perturbed lung microbiomes are implicated in both the …
- 間質性肺疾患治療の新境地
[PDF] WNT Through the Ranks: A Mesenchymal FOXF1-WNT5A Axis Sways Hierarchical Decisions in Alveolar Epithelial Development
E El Agha - American Journal of Respiratory Cell and Molecular …, 2023
… In this context, AEC2 hyperplasia is a feature of lung pathologies such as
idiopathic pulmonary fibrosis (IPF) and alveolar capillary dysplasia with
misalignment of pulmonary veins (ACDMPV). The latter is a rare congenital disorder …
- Ranksを介したWNT：間葉FOXF1-WNT5A軸は、肺胞上皮発生における階層的決定を揺るがす
<><><>
特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。
当面、毎週アラートの内容をアップしていこうと思います。
癒しの音楽をお届けいたします。
###
